Form 8-K - Current report:
SEC Accession No. 0001615774-17-007343
Filing Date
2017-12-15
Accepted
2017-12-15 07:31:02
Documents
1
Period of Report
2017-12-14
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K s108441_8k.htm 8-K 22147
  Complete submission text file 0001615774-17-007343.txt   23422
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24006 | Film No.: 171257691
SIC: 2834 Pharmaceutical Preparations